Emeis share falls below €9.78, an unprecedented low in one year
The manager of elderly care facilities is accelerating its decline mid-session, in a downward-oriented Paris market. The security enters uncharted territory for more than a year, far from its medium-term benchmarks.
A new low over 250 sessions that opens unsupported territory
Emeis declines 2.05% to €9.58, while the SBF 120 falls 0.72% and the CAC 40 loses 0.8%. The security has just broken through €9.78, the lowest of the last 250 sessions, which had served as a floor and now becomes a resistance level. Below the current price, no other support has been identified. The RSI has dropped to 24, a sign of seller exhaustion following a 20% decline over one month and 31.4% over three months.
The price is also 5.94% below its 20-day moving average and 29.60% below its 200-day moving average, a gap that measures the extent of the slide. In the SBF 120, Emeis ranks among the lowest performers of the session. Tension in French debt adds to the picture: the 10-year OAT stands at 5.13% according to the Banque de France reading of October 22, its highest level since 2004, and the spread with the Bund reaches 1.75 points.
Third quarter activity update expected on October 29
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The company's next appointment is scheduled for October 29, with the publication of the third quarter 2026 activity update. During the first half results, published on July 29, 2026, the group had indicated that the period's performance warranted an upward revision of its 2026 guidance. It also specified that the trend since the beginning of the year confirmed the momentum observed in 2025. The share price, meanwhile, has taken the opposite direction: it has lost 29.8% over one year.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
